ID   RAB9A_HUMAN             Reviewed;         201 AA.
AC   P51151; A8K390; Q6ICN1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   18-JUN-2025, entry version 225.
DE   RecName: Full=Ras-related protein Rab-9A;
DE            EC=3.6.5.2 {ECO:0000250|UniProtKB:P62820};
GN   Name=RAB9A {ECO:0000312|HGNC:HGNC:9792}; Synonyms=RAB9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9126495; DOI=10.1006/geno.1997.4644;
RA   Davies J.P., Cotter P.D., Ioannou Y.A.;
RT   "Cloning and mapping of human Rab7 and Rab9 cDNA sequences and
RT   identification of a Rab9 pseudogene.";
RL   Genomics 41:131-134(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16176980; DOI=10.1091/mbc.e05-03-0189;
RA   Johansson M., Lehto M., Tanhuanpaeae K., Cover T.L., Olkkonen V.M.;
RT   "The oxysterol-binding protein homologue ORP1L interacts with Rab7 and
RT   alters functional properties of late endocytic compartments.";
RL   Mol. Biol. Cell 16:5480-5492(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-179, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   INTERACTION WITH GCC2.
RX   PubMed=16885419; DOI=10.1091/mbc.e06-02-0153;
RA   Reddy J.V., Burguete A.S., Sridevi K., Ganley I.G., Nottingham R.M.,
RA   Pfeffer S.R.;
RT   "A functional role for the GCC185 golgin in mannose 6-phosphate receptor
RT   recycling.";
RL   Mol. Biol. Cell 17:4353-4363(2006).
RN   [10]
RP   INTERACTION WITH GCC2.
RX   PubMed=18243103; DOI=10.1016/j.cell.2007.11.048;
RA   Burguete A.S., Fenn T.D., Brunger A.T., Pfeffer S.R.;
RT   "Rab and Arl GTPase family members cooperate in the localization of the
RT   golgin GCC185.";
RL   Cell 132:286-298(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   INTERACTION WITH HPS4 AND BLOC-3 COMPLEX, ABSENCE OF INTERACTION WITH HPS1,
RP   AND MUTAGENESIS OF ILE-40; PHE-44; TRP-61 AND GLN-66.
RX   PubMed=20048159; DOI=10.1074/jbc.m109.069088;
RA   Kloer D.P., Rojas R., Ivan V., Moriyama K., van Vlijmen T., Murthy N.,
RA   Ghirlando R., van der Sluijs P., Hurley J.H., Bonifacino J.S.;
RT   "Assembly of the biogenesis of lysosome-related organelles complex-3 (BLOC-
RT   3) and its interaction with Rab9.";
RL   J. Biol. Chem. 285:7794-7804(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   INTERACTION WITH SGSM2.
RX   PubMed=21808068; DOI=10.1074/jbc.m111.261115;
RA   Nottingham R.M., Ganley I.G., Barr F.A., Lambright D.G., Pfeffer S.R.;
RT   "RUTBC1 protein, a Rab9A effector that activates GTP hydrolysis by Rab32
RT   and Rab33B proteins.";
RL   J. Biol. Chem. 286:33213-33222(2011).
RN   [16]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21255211; DOI=10.1111/j.1600-0854.2011.01165.x;
RA   Seto S., Tsujimura K., Koide Y.;
RT   "Rab GTPases regulating phagosome maturation are differentially recruited
RT   to mycobacterial phagosomes.";
RL   Traffic 12:407-420(2011).
RN   [17]
RP   INTERACTION WITH SGSM1.
RX   PubMed=22637480; DOI=10.1074/jbc.m112.362558;
RA   Nottingham R.M., Pusapati G.V., Ganley I.G., Barr F.A., Lambright D.G.,
RA   Pfeffer S.R.;
RT   "RUTBC2 protein, a Rab9A effector and GTPase-activating protein for
RT   Rab36.";
RL   J. Biol. Chem. 287:22740-22748(2012).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-187, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22] {ECO:0007744|PDB:1WMS}
RP   X-RAY CRYSTALLOGRAPHY (1.25 ANGSTROMS) OF 1-177 IN COMPLEX WITH GDP.
RX   PubMed=15263003; DOI=10.1074/jbc.m407114200;
RA   Chen L., DiGiammarino E., Zhou X.E., Wang Y., Toh D., Hodge T.W.,
RA   Meehan E.J.;
RT   "High resolution crystal structure of human Rab9 GTPase: a novel antiviral
RT   drug target.";
RL   J. Biol. Chem. 279:40204-40208(2004).
RN   [23] {ECO:0007744|PDB:7E1T}
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) IN COMPLEX WITH GTP; MG(2+) AND
RP   NDE1, FUNCTION, INTERACTION WITH NDE1, COFACTOR, SUBCELLULAR LOCATION,
RP   MUTAGENESIS OF ILE-40; GLU-43; PHE-44; ASN-46; TRP-61 AND LEU-72, AND
RP   DOMAIN.
RX   PubMed=34793709; DOI=10.1016/j.str.2021.10.013;
RA   Zhang Y., Chen Z., Wang F., Sun H., Zhu X., Ding J., Zhang T.;
RT   "Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein
RT   motor complex.";
RL   Structure 30:386-395.e5(2022).
CC   -!- FUNCTION: The small GTPases Rab are key regulators of intracellular
CC       membrane trafficking, from the formation of transport vesicles to their
CC       fusion with membranes. Rabs cycle between an inactive GDP-bound form
CC       and an active GTP-bound form that is able to recruit to membranes
CC       different sets of downstream effectors directly responsible for vesicle
CC       formation, movement, tethering and fusion (By similarity). RAB9A is
CC       involved in the transport of proteins between the endosomes and the
CC       trans-Golgi network (TGN) (PubMed:34793709). Specifically uses
CC       NDE1/NDEL1 as an effector to interact with the dynein motor complex in
CC       order to control retrograde trafficking of RAB9-associated late
CC       endosomes to the TGN (PubMed:34793709). Involved in the recruitment of
CC       SGSM2 to melanosomes and is required for the proper trafficking of
CC       melanogenic enzymes TYR, TYRP1 and DCT/TYRP2 to melanosomes in
CC       melanocytes (By similarity). {ECO:0000250|UniProtKB:P24408,
CC       ECO:0000250|UniProtKB:P62820, ECO:0000269|PubMed:34793709}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP + H2O = GDP + phosphate + H(+); Xref=Rhea:RHEA:19669,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58189; EC=3.6.5.2;
CC         Evidence={ECO:0000250|UniProtKB:P62820};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19670;
CC         Evidence={ECO:0000250|UniProtKB:P62820};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:34793709};
CC   -!- ACTIVITY REGULATION: Regulated by guanine nucleotide exchange factors
CC       (GEFs) which promote the exchange of bound GDP for free GTP. Regulated
CC       by GTPase activating proteins (GAPs) which increase the GTP hydrolysis
CC       activity. Inhibited by GDP dissociation inhibitors (GDIs).
CC       {ECO:0000305}.
CC   -!- SUBUNIT: Interacts (preferentially in its GTP-bound form) with GCC2
CC       (via its GRIP domain) (PubMed:16885419, PubMed:18243103). Interacts
CC       (GTP-bound form) with SGSM1; the GDP-bound form has much lower affinity
CC       for SGSM1 (PubMed:22637480). Interacts with SGSM2 (PubMed:21808068).
CC       The GTP-bound form but not the GDP-bound form interacts with HPS4 and
CC       BLOC-3 complex (heterodimer of HPS1 and HPS4) but does not interact
CC       with HPS1 alone (PubMed:20048159). Interacts (GTP-bound form) with
CC       NDE1; two RAB9A-GTP molecules lie on the opposite sides of the NDE1
CC       homodimer; the interaction leads to RAB9A-dynein motor tethering
CC       (PubMed:34793709). Interacts (GTP-bound form) with NDEL1
CC       (PubMed:34793709). {ECO:0000269|PubMed:16885419,
CC       ECO:0000269|PubMed:18243103, ECO:0000269|PubMed:20048159,
CC       ECO:0000269|PubMed:21808068, ECO:0000269|PubMed:22637480,
CC       ECO:0000269|PubMed:34793709}.
CC   -!- INTERACTION:
CC       P51151; Q9Y2I1: NISCH; NbExp=8; IntAct=EBI-4401353, EBI-2688731;
CC       P51151; Q8IWE5: PLEKHM2; NbExp=4; IntAct=EBI-4401353, EBI-726484;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor
CC       {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Endoplasmic reticulum
CC       membrane {ECO:0000305}. Golgi apparatus membrane
CC       {ECO:0000305|PubMed:34793709}. Late endosome
CC       {ECO:0000269|PubMed:16176980, ECO:0000269|PubMed:34793709}. Cytoplasmic
CC       vesicle, phagosome membrane {ECO:0000305}; Lipid-anchor {ECO:0000305};
CC       Cytoplasmic side {ECO:0000305}. Cytoplasmic vesicle, phagosome
CC       {ECO:0000269|PubMed:21255211}. Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:34793709}. Melanosome
CC       {ECO:0000250|UniProtKB:Q9R0M6}. Note=Colocalizes with OSBPL1A at the
CC       late endosome (PubMed:16176980). Recruited to phagosomes containing
CC       S.aureus or M.tuberculosis (PubMed:21255211). Mainly localizes to late
CC       endosomes and partially localizes to Golgi (PubMed:34793709).
CC       Colocalizes with NDE1 to membrane vesicles (PubMed:34793709).
CC       {ECO:0000269|PubMed:16176980, ECO:0000269|PubMed:21255211,
CC       ECO:0000269|PubMed:34793709}.
CC   -!- DOMAIN: Switch 1, switch 2 and the interswitch regions are
CC       characteristic of Rab GTPases and mediate the interactions with Rab
CC       downstream effectors. The switch regions undergo conformational changes
CC       upon nucleotide binding which drives interaction with specific sets of
CC       effector proteins, with most effectors only binding to GTP-bound Rab.
CC       {ECO:0000269|PubMed:34793709}.
CC   -!- SIMILARITY: Belongs to the small GTPase superfamily. Rab family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U44103; AAC51200.1; -; mRNA.
DR   EMBL; AF498944; AAM21092.1; -; mRNA.
DR   EMBL; CR450362; CAG29358.1; -; mRNA.
DR   EMBL; AK290505; BAF83194.1; -; mRNA.
DR   EMBL; CH471074; EAW98826.1; -; Genomic_DNA.
DR   EMBL; BC017265; AAH17265.1; -; mRNA.
DR   CCDS; CCDS14156.1; -.
DR   PIR; G02361; G02361.
DR   RefSeq; NP_001182257.1; NM_001195328.2.
DR   RefSeq; NP_004242.1; NM_004251.5.
DR   RefSeq; XP_016885453.1; XM_017029964.1.
DR   RefSeq; XP_047298600.1; XM_047442644.1.
DR   RefSeq; XP_047298601.1; XM_047442645.1.
DR   RefSeq; XP_054184110.1; XM_054328135.1.
DR   RefSeq; XP_054184111.1; XM_054328136.1.
DR   PDB; 1WMS; X-ray; 1.25 A; A/B=1-177.
DR   PDB; 7E1T; X-ray; 2.45 A; A/B=1-201.
DR   PDBsum; 1WMS; -.
DR   PDBsum; 7E1T; -.
DR   AlphaFoldDB; P51151; -.
DR   SMR; P51151; -.
DR   BioGRID; 114768; 597.
DR   CORUM; P51151; -.
DR   DIP; DIP-46409N; -.
DR   FunCoup; P51151; 768.
DR   IntAct; P51151; 194.
DR   MINT; P51151; -.
DR   STRING; 9606.ENSP00000420127; -.
DR   ChEMBL; CHEMBL1293294; -.
DR   DrugBank; DB03793; Benzoic acid.
DR   DrugBank; DB04315; Guanosine-5'-Diphosphate.
DR   GlyGen; P51151; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P51151; -.
DR   PhosphoSitePlus; P51151; -.
DR   SwissPalm; P51151; -.
DR   BioMuta; RAB9A; -.
DR   DMDM; 1710003; -.
DR   jPOST; P51151; -.
DR   MassIVE; P51151; -.
DR   PaxDb; 9606-ENSP00000420127; -.
DR   PeptideAtlas; P51151; -.
DR   ProteomicsDB; 56285; -.
DR   Pumba; P51151; -.
DR   Antibodypedia; 513; 293 antibodies from 35 providers.
DR   DNASU; 9367; -.
DR   Ensembl; ENST00000464506.2; ENSP00000420127.1; ENSG00000123595.8.
DR   Ensembl; ENST00000618931.2; ENSP00000480777.1; ENSG00000123595.8.
DR   GeneID; 9367; -.
DR   KEGG; hsa:9367; -.
DR   MANE-Select; ENST00000464506.2; ENSP00000420127.1; NM_004251.5; NP_004242.1.
DR   UCSC; uc004cvm.5; human.
DR   AGR; HGNC:9792; -.
DR   CTD; 9367; -.
DR   DisGeNET; 9367; -.
DR   GeneCards; RAB9A; -.
DR   HGNC; HGNC:9792; RAB9A.
DR   HPA; ENSG00000123595; Low tissue specificity.
DR   MIM; 300284; gene.
DR   OpenTargets; ENSG00000123595; -.
DR   VEuPathDB; HostDB:ENSG00000123595; -.
DR   eggNOG; KOG0394; Eukaryota.
DR   GeneTree; ENSGT00940000158619; -.
DR   HOGENOM; CLU_041217_10_6_1; -.
DR   InParanoid; P51151; -.
DR   OMA; WCAEQKV; -.
DR   OrthoDB; 1436450at2759; -.
DR   PAN-GO; P51151; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; P51151; -.
DR   PathwayCommons; P51151; -.
DR   Reactome; R-HSA-6811440; Retrograde transport at the Trans-Golgi-Network.
DR   Reactome; R-HSA-8873719; RAB geranylgeranylation.
DR   Reactome; R-HSA-8876198; RAB GEFs exchange GTP for GDP on RABs.
DR   Reactome; R-HSA-9706019; RHOBTB3 ATPase cycle.
DR   SignaLink; P51151; -.
DR   SIGNOR; P51151; -.
DR   BioGRID-ORCS; 9367; 18 hits in 779 CRISPR screens.
DR   ChiTaRS; RAB9A; human.
DR   EvolutionaryTrace; P51151; -.
DR   GeneWiki; RAB9A; -.
DR   GenomeRNAi; 9367; -.
DR   Pharos; P51151; Tbio.
DR   PRO; PR:P51151; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; P51151; protein.
DR   Bgee; ENSG00000123595; Expressed in amniotic fluid and 208 other cell types or tissues.
DR   ExpressionAtlas; P51151; baseline and differential.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005770; C:late endosome; IDA:MGI.
DR   GO; GO:0005764; C:lysosome; IDA:MGI.
DR   GO; GO:0042470; C:melanosome; ISS:UniProtKB.
DR   GO; GO:0045335; C:phagocytic vesicle; IDA:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032588; C:trans-Golgi network membrane; TAS:Reactome.
DR   GO; GO:0030133; C:transport vesicle; TAS:Reactome.
DR   GO; GO:0003925; F:G protein activity; IDA:GO_Central.
DR   GO; GO:0019003; F:GDP binding; IDA:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IDA:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0045921; P:positive regulation of exocytosis; IMP:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0032482; P:Rab protein signal transduction; IEA:InterPro.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IDA:GO_Central.
DR   GO; GO:0032880; P:regulation of protein localization; IMP:AgBase.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IBA:GO_Central.
DR   CDD; cd04116; Rab9; 1.
DR   FunFam; 3.40.50.300:FF:000360; RAB9B, member RAS oncogene family; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR041824; Rab9.
DR   InterPro; IPR005225; Small_GTP-bd.
DR   InterPro; IPR001806; Small_GTPase.
DR   NCBIfam; TIGR00231; small_GTP; 1.
DR   PANTHER; PTHR47981; RAB FAMILY; 1.
DR   PANTHER; PTHR47981:SF9; RAS-RELATED PROTEIN RAB-9A; 1.
DR   Pfam; PF00071; Ras; 1.
DR   PRINTS; PR00449; RASTRNSFRMNG.
DR   SMART; SM00175; RAB; 1.
DR   SMART; SM00176; RAN; 1.
DR   SMART; SM00173; RAS; 1.
DR   SMART; SM00174; RHO; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS51419; RAB; 1.
DR   neXtProt; NX_P51151; -.
DR   PharmGKB; PA34152; -.
DR   TreeFam; TF326442; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell membrane; Cytoplasmic vesicle;
KW   Endoplasmic reticulum; Endosome; Golgi apparatus; GTP-binding; Hydrolase;
KW   Lipoprotein; Membrane; Nucleotide-binding; Phosphoprotein; Prenylation;
KW   Protein transport; Proteomics identification; Reference proteome;
KW   Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CHAIN           2..201
FT                   /note="Ras-related protein Rab-9A"
FT                   /id="PRO_0000121139"
FT   MOTIF           31..42
FT                   /note="Switch 1"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   MOTIF           64..78
FT                   /note="Switch 2"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         17
FT                   /ligand="GDP"
FT                   /ligand_id="ChEBI:CHEBI:58189"
FT                   /evidence="ECO:0000269|PubMed:15263003,
FT                   ECO:0007744|PDB:1WMS"
FT   BINDING         17
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         18
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         19
FT                   /ligand="GDP"
FT                   /ligand_id="ChEBI:CHEBI:58189"
FT                   /evidence="ECO:0000269|PubMed:15263003,
FT                   ECO:0007744|PDB:1WMS"
FT   BINDING         19
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         20
FT                   /ligand="GDP"
FT                   /ligand_id="ChEBI:CHEBI:58189"
FT                   /evidence="ECO:0000269|PubMed:15263003,
FT                   ECO:0007744|PDB:1WMS"
FT   BINDING         20
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         21
FT                   /ligand="GDP"
FT                   /ligand_id="ChEBI:CHEBI:58189"
FT                   /evidence="ECO:0000269|PubMed:15263003,
FT                   ECO:0007744|PDB:1WMS"
FT   BINDING         21
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         21
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         22
FT                   /ligand="GDP"
FT                   /ligand_id="ChEBI:CHEBI:58189"
FT                   /evidence="ECO:0000269|PubMed:15263003,
FT                   ECO:0007744|PDB:1WMS"
FT   BINDING         22
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         34
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         38
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         39
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         39
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         62
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         65
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         124
FT                   /ligand="GDP"
FT                   /ligand_id="ChEBI:CHEBI:58189"
FT                   /evidence="ECO:0000269|PubMed:15263003,
FT                   ECO:0007744|PDB:1WMS"
FT   BINDING         124
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         125
FT                   /ligand="GDP"
FT                   /ligand_id="ChEBI:CHEBI:58189"
FT                   /evidence="ECO:0000269|PubMed:15263003,
FT                   ECO:0007744|PDB:1WMS"
FT   BINDING         125
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         127
FT                   /ligand="GDP"
FT                   /ligand_id="ChEBI:CHEBI:58189"
FT                   /evidence="ECO:0000269|PubMed:15263003,
FT                   ECO:0007744|PDB:1WMS"
FT   BINDING         127
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         155
FT                   /ligand="GDP"
FT                   /ligand_id="ChEBI:CHEBI:58189"
FT                   /evidence="ECO:0000269|PubMed:15263003,
FT                   ECO:0007744|PDB:1WMS"
FT   BINDING         155
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   BINDING         156
FT                   /ligand="GDP"
FT                   /ligand_id="ChEBI:CHEBI:58189"
FT                   /evidence="ECO:0000269|PubMed:15263003,
FT                   ECO:0007744|PDB:1WMS"
FT   BINDING         156
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:34793709,
FT                   ECO:0007744|PDB:7E1T"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         179
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983"
FT   MOD_RES         187
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   LIPID           200
FT                   /note="S-geranylgeranyl cysteine"
FT                   /evidence="ECO:0000250"
FT   LIPID           201
FT                   /note="S-geranylgeranyl cysteine"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         40
FT                   /note="I->L: Loss of interaction with HPS4; when associated
FT                   with L-66."
FT                   /evidence="ECO:0000269|PubMed:20048159"
FT   MUTAGEN         40
FT                   /note="I->R: Loss of interaction with NDE1 and the dynein
FT                   complex. Loss of localization to intracellular membrane
FT                   vesicles."
FT                   /evidence="ECO:0000269|PubMed:34793709"
FT   MUTAGEN         43
FT                   /note="E->A: Decreased interaction with NDE1."
FT                   /evidence="ECO:0000269|PubMed:34793709"
FT   MUTAGEN         44
FT                   /note="F->D: Loss of interaction with NDE1 and the dynein
FT                   complex. Loss of localization to intracellular membrane
FT                   vesicles."
FT                   /evidence="ECO:0000269|PubMed:34793709"
FT   MUTAGEN         44
FT                   /note="F->L: Loss of interaction with HPS4; when associated
FT                   with L-66."
FT                   /evidence="ECO:0000269|PubMed:20048159"
FT   MUTAGEN         46
FT                   /note="N->A,I,S,T,V: Loss of interaction with NDE1."
FT                   /evidence="ECO:0000269|PubMed:34793709"
FT   MUTAGEN         61
FT                   /note="W->D: Loss of interaction with NDE1. No change in
FT                   localization to intracellular membrane vesicles."
FT                   /evidence="ECO:0000269|PubMed:34793709"
FT   MUTAGEN         61
FT                   /note="W->L: Loss of interaction with HPS4; when associated
FT                   with L-66."
FT                   /evidence="ECO:0000269|PubMed:20048159"
FT   MUTAGEN         66
FT                   /note="Q->L: Loss of interaction with HPS4; when associated
FT                   with L-40 or L-44 or L-61."
FT                   /evidence="ECO:0000269|PubMed:20048159"
FT   MUTAGEN         72
FT                   /note="L->D: Loss of interaction with NDE1 and the dynein
FT                   complex. Loss of localization to intracellular membrane
FT                   vesicles."
FT                   /evidence="ECO:0000269|PubMed:34793709"
FT   STRAND          5..13
FT                   /evidence="ECO:0007829|PDB:1WMS"
FT   HELIX           20..29
FT                   /evidence="ECO:0007829|PDB:1WMS"
FT   STRAND          41..51
FT                   /evidence="ECO:0007829|PDB:1WMS"
FT   STRAND          54..62
FT                   /evidence="ECO:0007829|PDB:1WMS"
FT   HELIX           67..69
FT                   /evidence="ECO:0007829|PDB:1WMS"
FT   HELIX           70..73
FT                   /evidence="ECO:0007829|PDB:1WMS"
FT   HELIX           74..77
FT                   /evidence="ECO:0007829|PDB:1WMS"
FT   STRAND          81..88
FT                   /evidence="ECO:0007829|PDB:1WMS"
FT   HELIX           92..96
FT                   /evidence="ECO:0007829|PDB:1WMS"
FT   HELIX           98..109
FT                   /evidence="ECO:0007829|PDB:1WMS"
FT   TURN            114..116
FT                   /evidence="ECO:0007829|PDB:1WMS"
FT   STRAND          119..124
FT                   /evidence="ECO:0007829|PDB:1WMS"
FT   HELIX           135..144
FT                   /evidence="ECO:0007829|PDB:1WMS"
FT   STRAND          150..152
FT                   /evidence="ECO:0007829|PDB:1WMS"
FT   TURN            155..157
FT                   /evidence="ECO:0007829|PDB:1WMS"
FT   HELIX           161..173
FT                   /evidence="ECO:0007829|PDB:1WMS"
SQ   SEQUENCE   201 AA;  22838 MW;  65B502C21E97DB72 CRC64;
     MAGKSSLFKV ILLGDGGVGK SSLMNRYVTN KFDTQLFHTI GVEFLNKDLE VDGHFVTMQI
     WDTAGQERFR SLRTPFYRGS DCCLLTFSVD DSQSFQNLSN WKKEFIYYAD VKEPESFPFV
     ILGNKIDISE RQVSTEEAQA WCRDNGDYPY FETSAKDATN VAAAFEEAVR RVLATEDRSD
     HLIQTDTVNL HRKPKPSSSC C
//
